Does Rabeprazole Sodium Alleviate the Anti-diabetic Activity of Linagliptin? Drug-Drug Interaction Analysis by In vitro and In vivo Methods

Abstract

Drug interaction has turned into the preeminent regarding issues for a prescriber during polypharmacy. The foremost objective of this research was to form a complex between linagliptin and rabeprazole sodium by in vitro interactions. The interactions between the drugs have been examined by monitoring some chromatographic and spectroscopic analyses viz. TLC, HPLC, FT-IR, UV, Job’s plot, conductometric titrations, and Ardon’s spectrophotometric strategy. Rabeprazole sodium formed a stable complex with linagliptin, which was ensured from the insight of these analytical data. The developed complex’s bright spot was clearly watched in the TLC plate. The retention time (R_t) of the formed complex was 5.303 min, where the R_t were 3.364 and 3.103 min for linagliptin and rabeprazole sodium, respectively, in HPLC chromatograms. In FT-IR and UV spectra of the formed complex revealed some disappearance of characteristic peaks that affirmed the complexation. All of the variations of the spectrophotometric and chromatographic properties from the antecedent drugs indicated the drug-drug interaction. Another crucial fact for the experimental aim was to affirm the assumed drug interaction by in vivo model examination. The assessment of anti-diabetic property on alloxan-induced Swiss albino mice proved significant in vivo interaction between the drugs. It was outlined from the animal study that the hypoglycemic activity of linagliptin might be significantly affected due to the complex formation of the drug with a proton pump inhibitor (PPI). Nonetheless, it is the primary outcome of the interaction, which recommends the bigger in vivo study or clinical monitoring on the human model.

Key words

Drug interaction - Job’s plot - conductometric titrations - Ardon’s method - hypoglycemic property - TLC - HPLC - FT-IR - UV

Publication History

Received: 07 May 2020

Accepted: 01 August 2020

Article published online:
11 September 2020

• References

• 1 Weistein ZB, Zaman MH. Quantitative bioassay to identify antimicrobial drugs through drug interaction fingerprint analysis. Sci Rep 2017; DOI: 10.1038/srep42644.
• 2 Tannenbaum C, Sheehan NL. Understanding and preventing drug–drug and drug–gene interactions. Expert Rev Clin Pharmacol 2014; 7: 533-544
• 3 Ahsan MR, Sultan MZ, Amjad FM. et al. Complexation of ciprofloxacin with paracetamol and zinc in aqueous medium. J Sci Res 2012; 4: 701-708
• 4 Gallwitz B. Emerging DPP-4 inhibitors: Focus on linagliptin for type 2 diabetes. Diabet Metab Synd Ob Targets Ther 2013; 6: 1-9
• 5 Freeman MK. Efficacy and safety of linagliptin (tradjenta) in adults with type-2 diabetes mellitus. Pharm Ther 2011; 36: 807-813
• 6 Graefe-mody U, Retlich S, Friedrich C. et al. Clinical pharmacokinetics and pharmacodynamics of linagliptin. Clin Pharmacokinet 2012; 51: 411-427
• 7 Sortino MA, Sinagra T, Canonico PL. Linagliptin: A thorough characterization beyond its clinical efficacy. Front Endocrinol 2020; 4 doi: 10.3389/fendo.2013.00016
• 8 Retlich S, Duval V, Grafey-Mody U. et al. Population pharmacokinetics and pharmacodynamics of linagliptin in patients with type 2 diabetes mellitus. Clin Pharmacokinet 2015; 54: 737-750
• 9 Abdel-hay MH, Sabry SM, Belal TS. et al. Spectrophotometric determination of rabeprazole sodium using two charge transfer complexation reactions. J App Pharm Sci 2013; 3: 128-133
• 10 Garcia CV, Nudelman NS, Steppe M. et al. Structural elucidation of rabeprazole sodium photodegradation products. J Pharm Biomed Anal 2008; 46: 88-93
• 11 Swan SK, Hoyumpa AM, Merritt GJ. Review: The pharmacokinetics of rabeprazole in health and disease. Aliment Pharmacol Ther 1999; 13: 11-17
• 12 Langtry HD, Markham A. Rabeprazole: A Review of its use in acid-related gastrointestinal disorders. Drugs 1999; 58: 725-742
• 13 Saha S, Begum R, Sultan Z. et al. In vitro interaction of metformin with diclofenac in aqueous medium. Dhaka Univ. J Pharm Sci 2012; 11: 101-106
• 14 Boonsongrit Y, Mueller BW, Mitrevej A. Characterization of drug-chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry. Eur J Pharm Biopharm 2008; 69: 388-395
• 15 Sayeed MA, Habib R, Rahman M. et al. In vitro study on the interaction of ketotifen fumarate with anhydrous theophylline. Braz J Pharm Sci 2012; 48 DOI: 10.1590/S1984-82502012000200004.
• 16 Saha S, Begum R, Rahman A. et al. Evaluation of in vitro interaction of metformin with ibuprofen in aqueous medium. Bangladesh Pharm J 2013; 16: 189-194
• 17 Afzal M, Sultan Z, Begum R. et al. In vitro interaction of nandrolone with calcium nitrate, magnesium sulfate and potassium permanganate in aqueous medium. Dhaka Univ. J Pharm Sci 2012; 11: 93-99
• 18 Ashfak K, Chowdhury A, Shah M. et al. In vitro, in vivo and in silico drug-drug interaction study between vildagliptin and bisoprolol fumarate. IIUC Studies 2017; 14: 29-44
• 19 Sayeed MA, Habib R, Rahman M. Evaluation of interaction between ketotifen fumerate and theophylline and their effects on protein binding. Bangladesh Pharm J 2011; 14: 133-140
• 20 Amran S, Bari AHMR, Hossain A. In vitro and in vivo interactions of diltiazem with ibuprofen and naproxen in aqueous medium and rabbits. Dhaka Univ J Pharm Sci 2006; 5: 25-28
• 21 Xu Z, Wang X, Zhou M. et al. The antidiabetic activity of total lignan from fructus arctii against alloxan-induced diabetes in mice and rats. Phytother Res 2008; 22: 97-101
• 22 Badole SL, Shah SN, Patel NM. et al. Hypoglycemic activity of aqueous extract of pleurotus pulmonarius in alloxan-induced diabetic mice. Pharm Biol 2006; 44: 421-425
• 23 Yin P, Wang Y, Yang L. et al. Hypoglycemic effects in alloxan-induced diabetic rats of the phenolic extract from mongolian oak cups enriched in ellagic acid, kaempferol and their derivatives. Molecules 2018; 23: 1046 DOI: 10.3390/molecules23051046.
• 24 Dra LA, Sellami S, Rais H. et al. Antidiabetic potential of Caralluma europaea against alloxan-induced diabetes in mice. Saudi J Biol Sci 2019; 26: 1171-1178
• 25 Lartey NL, Asare-Anane H, Ofori EK. et al. Antidiabetic activity of aqueous stem bark extract of Annickia polycarpa in alloxan-induced diabetic mice. J Tradit Complemen Med 2020; DOI: 10.1016/j.jtcme.2020.02.001.
• 26 Tafesse TB, Hymete A, Mekonnen Y. et al. Antidiabetic activity and phytochemical screening of extracts of the leaves of Ajuga remota Benth on alloxan-induced diabetic mice. BMC Complemen Alternat Med 2017; 17: 243. DOI: 10.1186/s12906-017-1757-5.
• 27 Patrick GL. An Introduction to Medicinal Chemistry. London: Oxford University Press; 2009: 653-682
• 28 Hosseini Nasab FA, Fekri LZ, Monfared A. et al. Recent advances in sulfur-nitrogen bond formation: Via cross-dehydrogenative coupling reactions. RSC Adv 2018; 8: 18456-18469
• 29 Hasan S, Kayesh R, Begum F. et al. Transition metal complexes of naproxen: synthesis, characterization, forced degradation studies, and analytical method verification. J Anal Methods Chem 2016; ID 3560695. DOI: 10.1155/2016/3560695.
• 30 Singh K, Kumar V. Synthesis, spectral and thermal studies of Co (II), Ni (II), Cu(II) and Zn (II) complexes derived from 1, 2, 4-triazole schiff bases. Int J Inorg. Bioorg Chem 2014; 4: 32-39
• 31 Aktar F, Sultan Z, Rashid MA. In vitro complexation of olmesartan medoxomil with dapagliflozin, vildagliptin and metformin. Dhaka Univ. J Pharm Sci 2019; 18: 271-280
• 32 Barden TA, De Abreu Engel RE, Campanharo SC. et al. Characterization of linagliptin using analytical techniques. Drug Anal Res 2017; 1: 30-37
• 33 Ajrin M, Sen N, Khan IN. et al. Effect of Ca (II) ion on the in vitro availability and protein binding of amlodipine besylate. J Pharm Res 2013; 7: 671-676